Dual chamber Dual wavelength improvement of onychomycosis low in pain and infection.
OVERVIEW

COMPONENTS & TECHNICAL SPECIFICATIONS
Type name | OnychoLaser |
---|---|
Operating wevelength | 405nm / 635nm |
Total output | 405nm / 635nm |
Mode of Operation | CW(Continuous Wave) |
Safety features | Emergency off switch, Safety interlock, KeyLock |
Dimensions | 530 x 445 x 410mm |
Mains supply | AC 220V, 60Hz |
Laser class | lll B |
Standard acoessories | Body, Foot plate, Laser protection glesses (for doctor, patoent), Key lock, Safety interlock, Power cable |
PHILOSOPHY OF TERASIS DNC PHILOSOPHY
Customer oriented research and development
For the maximum conveniences and utilities of customer, Onycholaser is equipped with dual chamber which enable both feet together treated at same time. The proven 4 lasers (2 * 635nm lasers and 2 * 405nm lasers) are adopted after the qualified inspection. For the safe approaching to patient s toenail without any contaminations and without any damages, onycholaser go through many tests and refer many related articles. So the exact targeting cross beam features are created after on those procedures. Independent 4 motors driving mechanism to operate 4 lasers enable exact positioning and effective radiation on targeted toenail each.
DUAL WAVELENGH OF ONYCHOLASER
The onycholaser consists of a dual chamber that can treat both feet at the same time.
Noninvasive lasers are used to improve onychomycosis
The onycholaser uses four diode lasers, a dual wavelength range, to accurately investigate the toenail fungus.
and The four independent motors that operate each laser create a cross beam that can be accurately targeted
It allows for accurate investigation of the infected claws.
405nm laser acts on the extermination of fungi, while 635nm laser helps the fungus destroy cell walls and circulate blood.
By OnychoLaser

By OnychoLaser 1

1. Laser ligths at dual wavelength of 405nm and 635nm are delivered to the tissue via a rotating laser module on the surface of the toenail.
2. The light enters the celland is absorbed by the chromophores, including the protein cytochrome c oxidase which increases ATP production.
3. As a result of this heightened activity, two molecules are affected : Adenosine Triphosphate (ATP), Reactive Oxygen Species (ROS)
By OnychoLaser 2

본 기기는 ‘의료용레이저조사기’로 의료기기에 해당하며,
사용상의 주의사항과 사용 방법을 숙지 후 사용하십시오.
CLINICAL STUDY : The treatment evaluation of C. albicans and T. mentagrophytes which cause Human Onychomycosis radiated by dual wavelength lasers (635nm+405nm)
Killing effect of C.albicans which 635 nm + 405 nm double wavelength exposure time
Since C.albicans showed a killing effect of 16.7% at 5 min, 42.6% at 12 min, 57.6% at 15 min and 69.2% at 20 min after irradiation, 635nm + 405nm Composite Wavelength The laser beam source was confirmed to kill by Candida albicans NCCP 32557 irradiation time.

Comparative sensitivity of Trichophyton and Aspergillus conidia to inactivation by violet-blue light exposure
Objectives: To investigate the use of 405 nm light for inhibiting the growth of selected species of dermatophytic and saprophytic fungi. Background data: The increasing incidence and resilience of dermatophytic fungal infections is a major issue, and alternative treatment methods are being sought.

ONYCHOLASER refer numerous scientific articles (SCI class) to provide more powerful phototherapy effects
Treating Onychomycosis The most common causative agent is Trichophyton mentagrophytes. (FEBRUARY 15,2001 / VOLUME 63,NUMBER 4 www.aafp.org/afp)
Onychomycosis: A Review ( The journal of Fungi ) Onychomycosis is the most common nail infective disorder. It is caused mainly by anthropophilic dermatophytes, in particular by T. mentagrophytes var. interdigitale. Yeasts, like Candida albicans. (2015)
Twice-daily red and blue light treatment for Candida albicans biofilm matrix development control. Phototherapy has been proposed as a direct means of affecting local bacterial infections. However, the use of phototherapy to prevent fungal biofilm development has received comparatively less attention. (2018)
